Chinanews.com, March 13th. According to news from the website of the State Food and Drug Administration on the 13th, according to the provisions of the "Prescription Drugs and Non-Prescription Drug Classification Management Measures (Trial)" (former State Drug Administration Order No. 10), the State Drug Administration After the demonstration and approval by the Bureau, Chaihuang Oral Liquid and Ejiao Capsules were converted from prescription drugs to non-prescription drugs.
The list of varieties and the template of non-prescription drug instructions are released together.
file screenshot
Relevant drug marketing authorization holders shall, in accordance with the "Measures for the Administration of Drug Registration" and other relevant regulations, file with the provincial drug supervision and management department for the record, and promptly notify the relevant medical institutions, Pharmaceutical companies and other units.
Other contents of the insert sheet other than those stipulated in the model insert sheet of non-prescription drugs shall be implemented according to the original approval document.
If the drug label involves relevant content, it shall be revised together.
For non-prescription drugs produced since the date of supplementary application filing, the original drug instructions shall not continue to be used.
(China New Finance and Economics)